SG’s Visvires New Protein co-leads Series A round for Dutch poultry startup In Ovo

Singapore-based VisVires New Protein (VVNP) has co-led an undisclosed Series A round for Dutch poultry startup In Ovo. The other lead investor is Evonik, a global specialty chemicals company.

According to a statement, the full financing round comes up to “several million dollars”. Investors in the round also include Leiden University, which In Ovo had spun out of.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter